介绍

本页面提供了有关 Jon Snodgres 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Jon Snodgres已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:RGEN / Repligen Corporation Chief Financial Officer 37,381
如何解读这些图表

以下图表显示了在Jon Snodgres进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Jon Snodgres 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2023-05-16 2023-05-16 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -710 37,381 -1.86 154.03 -109,361 5,757,795
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -3,674 38,091 -8.80 188.00 -690,712 7,161,108
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
A - Award 8,795 41,765 26.68
2023-03-06 2023-03-02 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,848 32,970 17.24
2023-03-01 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -521 28,122 -1.82 173.28 -90,279 4,872,980
2023-02-28 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -682 28,643 -2.33 173.44 -118,286 4,967,842
2023-02-17 2023-02-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5,647 29,325 -16.15 200.00 -1,129,400 5,865,000
2022-10-11 2022-10-07 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise X 466 34,972 1.35 59.52 27,736 2,081,533
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,400 34,506 -6.50 253.16 -607,584 8,735,539
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -4,298 36,906 -10.43 252.70 -1,086,105 9,326,146
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 970 41,204 2.41 215.58 209,113 8,882,758
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,047 40,234 8.19 86.10 262,347 3,464,147
2022-08-02 2022-08-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,000 37,187 -5.10 220.00 -440,000 8,181,140
2022-05-17 2022-05-13 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -712 39,187 -1.78 150.40 -107,085 5,893,725
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 1,214 2,574 89.26
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2,952 13,707 27.45
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,214 39,899 3.14 59.52 72,257 2,374,788
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,952 38,685 8.26 33.87 99,984 1,310,261
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -2,468 35,733 -6.46 196.70 -485,456 7,028,681
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,922 38,201 18.35
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -661 32,279 -2.01 196.70 -130,019 6,349,279
2022-03-02 2022-02-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -695 32,940 -2.07 196.70 -136,706 6,479,298
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,410 4,410
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -269 33,635 -0.79 189.21 -50,897 6,364,078
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,443 33,904 11.30
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -332 30,461 -1.08 182.42 -60,563 5,556,696
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
A - Award 900 30,793 3.01
2021-05-18 2021-05-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -470 31,893 -1.45 172.60 -81,122 5,504,732
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -600 32,363 -1.82 189.75 -113,850 6,140,879
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -603 32,963 -1.80 190.45 -114,841 6,277,803
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -500 33,566 -1.47 191.43 -95,715 6,425,539
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -900 34,066 -2.57 192.54 -173,286 6,559,068
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -242 34,966 -0.69 193.72 -46,880 6,773,614
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -500 35,208 -1.40 196.30 -98,150 6,911,330
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -200 35,708 -0.56 197.86 -39,572 7,065,185
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,910 2,910
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2,410 35,908 7.19
2021-01-26 2021-01-25 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 6,887 -36.74
2021-01-26 2021-01-25 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 33,498 13.56 33.87 135,480 1,134,577
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -59 29,498 -0.20 195.77 -11,550 5,774,823
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -571 29,557 -1.90 195.16 -111,436 5,768,344
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -218 30,128 -0.72 193.88 -42,266 5,841,217
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -918 30,346 -2.94 192.74 -176,935 5,848,888
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -202 31,264 -0.64 190.50 -38,481 5,955,792
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,333 31,466 -4.06 190.09 -253,390 5,981,372
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -656 32,799 -1.96 188.69 -123,781 6,188,843
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -3,086 0 -100.00
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -3,086 33,455 -8.45 193.00 -595,598 6,456,815
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,086 36,541 9.22 32.40 99,986 1,183,928
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -1,893 3,788 -33.32
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,893 33,455 6.00 59.52 112,671 1,991,242
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -705 31,562 -2.18 194.69 -137,256 6,144,806
2020-05-19 2020-05-15 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -660 32,267 -2.00 140.43 -92,684 4,531,255
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -9,024 3,086 -74.52
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -3,170 0 -100.00
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -846 32,927 -2.50 132.37 -111,985 4,358,547
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -3,013 33,773 -8.19 131.38 -395,848 4,437,097
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,700 36,786 -4.42 130.20 -221,340 4,789,537
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,612 38,486 -4.02 128.70 -207,464 4,953,148
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,865 40,098 -6.67 127.75 -366,004 5,122,520
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -5,358 42,963 -11.09 126.77 -679,234 5,446,420
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 9,024 48,321 22.96 32.40 292,378 1,565,600
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,170 39,297 8.77 26.05 82,578 1,023,687
2020-03-05 2020-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,045 36,127 -2.81 90.39 -94,458 3,265,520
2020-03-05 2020-03-03 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -610 37,172 -1.61 88.18 -53,790 3,277,827
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award -4,571 4,571 -50.00
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,686 37,782 14.16
2020-02-27 2020-02-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -946 31,096 -2.95 86.11 -81,460 2,677,677
2020-02-27 2020-02-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -154 32,042 -0.48 86.86 -13,376 2,783,168
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -1,957 3,170 -38.17
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -2,000 0 -100.00
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,957 32,196 6.47 26.05 50,980 838,706
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,000 30,239 7.08 24.50 49,000 740,856
2019-07-17 2019-07-15 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -295 28,239 -1.03 85.95 -25,355 2,427,142
2019-06-11 2019-02-28 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 5,681 5,681
2019-05-15 2019-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 8,000 28,534 38.96
2019-03-27 2019-03-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,009 20,534 -4.68 59.05 -59,581 1,212,533
2019-03-27 2019-03-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5,458 21,543 -20.21 58.45 -319,020 1,259,188
2019-03-05 2019-03-05 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,645 27,001 -8.92 58.52 -154,785 1,580,099
2019-03-05 2019-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,700 29,646 18.84
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 5,653 5,653
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,875 24,946 -6.99 58.88 -110,400 1,468,820
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,922 26,821 28.34
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -10,253 5,127 -66.66
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -6,055 12,110 -33.33
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 2,000 -66.67
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11,445 0 -100.00
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -31,753 20,899 -60.31 63.49 -2,015,915 1,326,823
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 10,253 52,652 24.18 26.05 267,091 1,371,585
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 6,055 42,399 16.66 32.40 196,182 1,373,728
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 36,344 12.37 24.50 98,000 890,428
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 11,445 32,344 54.76 26.20 299,859 847,413
2018-08-29 2018-08-28 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -14,460 20,899 -40.89 52.79 -763,359 1,103,281
2018-07-20 2018-07-18 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -295 35,359 -0.83 47.91 -14,134 1,694,085
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 20,659 20,659
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 10,680 35,654 42.76
2018-03-02 2018-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -2,470 24,974 -9.00 35.16 -86,843 878,061
2017-07-20 2017-07-18 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -345 27,444 -1.24 41.77 -14,411 1,146,336
2017-05-22 2017-02-23 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 18,165 18,165
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 6,000 -40.00
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 27,789 16.81 24.50 98,000 680,830
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,909 23,789 -7.43 34.91 -66,646 830,510
2017-03-21 2017-02-23 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 19,750 19,750
2017-03-01 2017-03-01 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1,630 25,698 -5.96 32.07 -52,273 824,117
2017-03-01 2017-02-23 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 19,750 19,750
2017-03-01 2017-02-23 4 RGEN REPLIGEN CORP
Common Stock
A - Award 9,875 27,328 56.58
2016-07-15 2016-07-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -324 17,453 -1.82 26.56 -8,605 463,552
2016-03-01 2016-02-29 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -748 17,777 -4.04 26.05 -19,485 463,091
2016-03-01 2016-02-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 15,380 15,380
2016-03-01 2016-02-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 7,905 18,525 74.44
2015-11-12 2015-07-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -325 10,620 -2.97 41.30 -13,422 438,606
2015-03-02 2015-02-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 11,445 11,445
2015-03-02 2015-02-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,945 10,945 118.90
2014-07-15 2014-07-14 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 10,000 10,000
2014-07-15 2014-07-14 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,000 5,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)